CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

Clinical trial NCT06839976 · RECRUITING

Trial details

NCT number: NCT06839976
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

SLE Systemic Lupus Erythematosus (SLE)CAR T Cell CART19 Cell Therapy Lupus Lupus Nephritis (LN)

Start date: 2025-05-06
Primary completion: 2030-02-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.